Indiana Biosciences Research Institute Inc
- Assets
- $179.4m
- Revenue
- $10.0m
- Investments
- $99.8m
- Employees
- 53
- Location
- Indianapolis, IN
- Founding
- 08/2014
- Data as of
- 12/2021
- EIN
- 46-2882271
Organization Overview
Indiana Biosciences Research Institute Inc is located in Indianapolis, IN. The organization was established in 2014. According to its NTEE Classification (U05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Science & Technology and related organizations. As of 12/2021, Indiana Biosciences Research Institute Inc employed 53 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Indiana Biosciences Research Institute Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Indiana Biosciences Research Institute Inc generated $10.0m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (22.9%) each year. All expenses for the organization totaled $13.7m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE IBRI IS AN INDEPENDENT LIFE SCIENCES RESEARCH INSTITUTE FOCUSED ON ADDRESSING MAJOR UNDERSERVED AREAS OF PUBLIC HEALTH INCLUDING DIABETES, PEDIATRIC RARE DISEASES, AND ALZHEIMER'S DISEASE. THE IBRI FACILITATES THE GROWTH OF THE BIOMEDICAL COMMUNITY BY ATTRACTING TALENT AND INDUSTRY TO THE STATE AND AIDES IN THE COMMERCIALIZATION OF TECHNOLOGIES TO FOSTER FURTHER ECONOMIC DEVELOPMENT.
Describe the Organization's Program Activity:
THE INSTITUTE'S SCIENTIFIC RESEARCH FOCUSES ON DISCOVERING INNOVATIVE SOLUTIONS FOR UNDERSERVED DISEASES, INCLUDING DIABETES, PEDIATRIC RARE DISEASES, AND ALZHEIMER'S DISEASE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Name Not Listed Director | Trustee | 0.5 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Strategic Investment Group Investment Services | 12/30/21 | $512,691 |
Blackink It It Support | 12/30/21 | $167,752 |
Hd Biosciences Inc Research Services | 12/30/21 | $229,228 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $354,873 |
| All other contributions, gifts, grants, and similar amounts not included above | $550,900 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $905,773 |
| Total Program Service Revenue | $1,351,832 |
| Investment income | $727,826 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | -$2,214 |
| Net Gain/Loss on Asset Sales | $7,025,705 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $10,008,922 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,514,613 |
| Compensation of current officers, directors, key employees. | $319,016 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $2,757,442 |
| Pension plan accruals and contributions | $124,500 |
| Other employee benefits | $76,603 |
| Payroll taxes | $270,929 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $87,828 |
| Fees for services: Accounting | $99,650 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $500 |
| Fees for services: Investment Management | $615,541 |
| Fees for services: Other | $799,506 |
| Advertising and promotion | $115,404 |
| Office expenses | $95,583 |
| Information technology | $537,499 |
| Royalties | $0 |
| Occupancy | $2,466,737 |
| Travel | $43,126 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $1,218 |
| Interest | $231,951 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,878,777 |
| Insurance | $71,057 |
| All other expenses | $0 |
| Total functional expenses | $13,681,600 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $1,613,809 |
| Pledges and grants receivable | $5,932,435 |
| Accounts receivable, net | $236,205 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $111,646 |
| Net Land, buildings, and equipment | $9,888,401 |
| Investments—publicly traded securities | $42,429,316 |
| Investments—other securities | $99,776,488 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $19,420,836 |
| Total assets | $179,409,136 |
| Accounts payable and accrued expenses | $1,276,693 |
| Grants payable | $0 |
| Deferred revenue | $1,476,436 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $8,256,475 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $19,925,140 |
| Total liabilities | $30,934,744 |
| Net assets without donor restrictions | $93,570,142 |
| Net assets with donor restrictions | $54,904,250 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $179,409,136 |
Grants Recieved
Over the last fiscal year, we have identified 2 grants that Indiana Biosciences Research Institute Inc has recieved totaling $781,874.
| Awarding Organization | Amount |
|---|---|
Lilly Endowment Inc Indianapolis, IN PURPOSE: EMPLOYEE MATCHING GIFT(S) | $671,877 |
Jdrf International New York, NY PURPOSE: BETA CELL REGENERATION | $109,997 |
Endowment Analysis
| Beg. Balance | $141,951,538 |
| Earnings | $7,184,390 |
| Net Contributions | $745,787 |
| Other Expense | $7,675,911 |
| Ending Balance | $142,205,804 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Indiana Biosciences Research Institute Inc Indianapolis, IN | $179,409,136 | $10,008,922 |
North American Council For Freight Efficiency Fort Wayne, IN | $945,729 | $1,448,155 |
Ethos Inc Elkhart, IN | $7,597,037 | $1,049,008 |
Metropolitan Unified Fiber Network Consortium Madison, WI | $1,464,123 | $855,539 |
Predicted Reported And Observed Outcomes Foundation Saint Louis, MO | $0 | $250,000 |
Institute For Innovation Inc South Bend, IN | $300,459 | $137 |
Innovative Pavement Research Foundation Rosemont, IL | $353,950 | $109,320 |
Concrete Nanotechnology And Nanoscience Society Milwaukee, WI | $21,033 | $0 |
Clinical Research Institute Lisle, IL | $1,160 | $0 |